The HCPLive ADHD condition center page is a comprehensive resource for clinical news and insights on ADHD. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for ADHD.
September 12th 2024
In an interview, lead investigator Lauren Moran, MD, shared how the results inform clinical practice on safe amphetamine dosing.
September 12th 2024
We knew obesity was a growing problem here in the U.S., and we knew that more children were being diagnosed with attention deficits. However, these chronic conditions don't appear to be the only ones on the rise; according to a study published today in JAMA, a number of diseases, including physical ailments such as allergies and other behavioral/learning disorders, are becoming more and prevalent, and in a big way.
ADHD as a Diagnostic Chameleon: Developing a Systematic Approach to Differential Diagnosis
February 8th 2008ADHD is a common presentation in all clinical settings. However, data shows that ADHD is underrecognized in adults.1 Why is this? Remember the old adage, "Out of sight, out of mind?" If ADHD is not thought of as a possibility in adult patients, is it more likely to be missed?
Perspectives on Efficacy: An Atomoxetine Tutorial
February 8th 2008This article provides answers to several common questions associated with the use of Strattera® (atomoxetine HCl) to treat patients with ADHD. Strattera is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children age 6 and older, adolescents, and adults.